down arrow

Glaxosmi. Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,754.05
90.6 (3.4%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 57.76 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

2,723.302,773.95

52 Week

1,825.053,087.95
Valuation
Technical
Day's Volume

CASH

57.76 k (-13.03%) Volume

Shareholding (Dec 2024)

FII

4.50%

Held by 261 FIIs

DII

7.31%

Held by 19 DIIs

Promoter

75.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 2.97% and Operating profit at 12.47% over the last 5 years

 
2

Flat results in Dec 24

3

Stock is technically in a Mildly Bearish range

4

With ROE of 46.9, it has a Very Expensive valuation with a 27 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 46,655 Cr (Large Cap)

stock-summary
P/E

53.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.65%

stock-summary
Debt Equity

-1.25

stock-summary
Return on Equity

46.87%

stock-summary
Price to Book

26.97

Revenue and Profits (1 Year):
Net Sales:
949 Cr
(Quarterly Results - Dec 2024)
Net Profit:
230 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.65%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-1.0%
0.45%
-0.55%
1 Year
45.33%
2.09%
47.42%
2 Years
114.82%
6.03%
120.85%
3 Years
66.86%
9.14%
76.0%
4 Years
90.49%
10.93%
101.42%
5 Years
97.67%
13.51%
111.18%

Latest dividend: 12 per share ex-dividend date: Nov-07-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
2.97%
EBIT Growth (5y)
12.47%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
2.01
Tax Ratio
26.69%
Dividend Payout Ratio
91.89%
Pledged Shares
0
Institutional Holding
11.81%
ROCE (avg)
-125.80%
ROE (avg)
54.93%
Valuation key factors
Factor
Value
P/E Ratio
53
Industry P/E
33
Price to Book Value
26.97
EV to EBIT
41.72
EV to EBITDA
39.06
EV to Capital Employed
-101.63
EV to Sales
11.61
PEG Ratio
1.43
Dividend Yield
1.65%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
46.87%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 35 Schemes (4.96%)

FIIs

Held by 261 FIIs (4.5%)

Promoter with highest holding

Glaxo Group Limited (35.99%)

Highest Public shareholder

Lici Asm Non Par (1.27%)

Individual Investors Holdings

10.96%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -6.07% vs 24.07% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -8.96% vs 38.49% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "949.42",
          "val2": "1,010.77",
          "chgp": "-6.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "291.92",
          "val2": "321.71",
          "chgp": "-9.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.27",
          "chgp": "-66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "4.69",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "229.88",
          "val2": "252.50",
          "chgp": "-8.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.75%",
          "val2": "31.83%",
          "chgp": "-1.08%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 6.21% vs 3.41% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 24.32% vs 11.85% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,825.42",
          "val2": "1,718.65",
          "chgp": "6.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "552.25",
          "val2": "433.37",
          "chgp": "27.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.64",
          "val2": "0.71",
          "chgp": "-9.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.69",
          "val2": "17.30",
          "chgp": "-72.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "434.83",
          "val2": "349.76",
          "chgp": "24.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.25%",
          "val2": "25.22%",
          "chgp": "5.03%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 9.94% vs 2.42% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 68.08% vs -17.14% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,774.84",
          "val2": "2,523.91",
          "chgp": "9.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "844.17",
          "val2": "651.43",
          "chgp": "29.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.73",
          "val2": "1.03",
          "chgp": "-29.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.69",
          "val2": "-146.01",
          "chgp": "103.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "664.71",
          "val2": "395.48",
          "chgp": "68.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.42%",
          "val2": "25.81%",
          "chgp": "4.61%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 6.21% vs -0.80% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -3.39% vs -63.97% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,453.71",
          "val2": "3,251.72",
          "chgp": "6.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "908.69",
          "val2": "804.29",
          "chgp": "12.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.80",
          "val2": "1.81",
          "chgp": "-0.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-143.61",
          "val2": "2.08",
          "chgp": "-7,004.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "589.96",
          "val2": "610.69",
          "chgp": "-3.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.31%",
          "val2": "24.73%",
          "chgp": "1.58%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
949.42
1,010.77
-6.07%
Operating Profit (PBDIT) excl Other Income
291.92
321.71
-9.26%
Interest
0.09
0.27
-66.67%
Exceptional Items
0.00
4.69
-100.00%
Consolidate Net Profit
229.88
252.50
-8.96%
Operating Profit Margin (Excl OI)
30.75%
31.83%
-1.08%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -6.07% vs 24.07% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -8.96% vs 38.49% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,825.42
1,718.65
6.21%
Operating Profit (PBDIT) excl Other Income
552.25
433.37
27.43%
Interest
0.64
0.71
-9.86%
Exceptional Items
4.69
17.30
-72.89%
Consolidate Net Profit
434.83
349.76
24.32%
Operating Profit Margin (Excl OI)
30.25%
25.22%
5.03%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 6.21% vs 3.41% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 24.32% vs 11.85% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,774.84
2,523.91
9.94%
Operating Profit (PBDIT) excl Other Income
844.17
651.43
29.59%
Interest
0.73
1.03
-29.13%
Exceptional Items
4.69
-146.01
103.21%
Consolidate Net Profit
664.71
395.48
68.08%
Operating Profit Margin (Excl OI)
30.42%
25.81%
4.61%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 9.94% vs 2.42% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 68.08% vs -17.14% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
3,453.71
3,251.72
6.21%
Operating Profit (PBDIT) excl Other Income
908.69
804.29
12.98%
Interest
1.80
1.81
-0.55%
Exceptional Items
-143.61
2.08
-7,004.33%
Consolidate Net Profit
589.96
610.69
-3.39%
Operating Profit Margin (Excl OI)
26.31%
24.73%
1.58%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 6.21% vs -0.80% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -3.39% vs -63.97% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Glaxosmithkline Pharmaceuticals Ltd stock-summary
stock-summary
Glaxosmithkline Pharmaceuticals Ltd
Large Cap
Pharmaceuticals & Drugs
GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is headquartered in Mumbai and it has six branch offices, a manufacturing facility at Nashik in Maharashtra, 22 contract manufacturing organisations (CMOs) with regional and sales hubs across India.
Company Coordinates stock-summary
Company Details
GSK House, Dr Annie Besant Road Worli Mumbai Maharashtra : 400030
stock-summary
Tel: 91-022-24959595
stock-summary
http://www.gsk-india.com
stock-summary
askus@gsk.com
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."